S’pore researchers in global search for Covid-19 vaccines

Duke-NUS Medical School (Duke-NUS) is working with United States medicine company Arcturus Therapeutics on a Covid-19 vaccine that gets the human body to produce part of the Sars-CoV-2 virus in order to fight it. In a separate collaboration, Dr Antonio Bertoleeti from Duke-NUS is working with Singapore-based biotechnology company Immunoscape to study Covid-specific T-cells in about 50 patients who have recovered from the disease.

• The Straits Times, 19 May 2020, Top of the News, Front Page & pA4-A5